← All companiesTTravere Therapeutics, Inc.
TVTX - CIK 0001438533
Travere Therapeutics, Inc. revenue by year
Travere Therapeutics, Inc. (TVTX) reported revenue of $490.73M for fiscal year 2025, as filed in its audited annual report with the SEC.
TVTX annual revenue
TVTX revenue 2011-2025
| Fiscal year | Revenue | Change |
|---|
| FY 2025 | $490.73M | +110.5% |
| FY 2024 | $233.18M | +60.5% |
| FY 2023 | $145.24M | +32.7% |
| FY 2022 | $109.46M | -17.0% |
| FY 2021 | $131.84M | -33.5% |
| FY 2020 | $198.32M | +13.1% |
| FY 2019 | $175.34M | +6.8% |
| FY 2018 | $164.25M | +6.0% |
| FY 2017 |
Revenue of similar companies
Frequently asked questions
How much revenue does Travere Therapeutics, Inc. make?
Travere Therapeutics, Inc. (TVTX) reported revenue of $490.73M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Travere Therapeutics, Inc.'s revenue changed over time?
Between fiscal 2011 and fiscal 2025, Travere Therapeutics, Inc.'s revenue grew from $0.00 to $490.73M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.